PRKACA ELISA Kit
-
- Target Alle PRKACA ELISA Kits anzeigen
- PRKACA (Protein Kinase A, alpha (PRKACA))
-
Reaktivität
- Maus
- Nachweismethode
- Colorimetric
- Methodentyp
- Sandwich ELISA
- Detektionsbereich
- 0.312 ng/mL - 20 ng/mL
- Untere Nachweisgrenze
- 0.312 ng/mL
- Applikation
- ELISA
- Verwendungszweck
- Mouse cAMP-dependent protein kinase catalytic subunit alpha ELISA Kit is an ELISA kit against Mouse cAMP-dependent protein kinase catalytic subunit alpha (Prkaca).
- Proben
- Plasma, Serum
- Analytische Methode
- Quantitative
- Featured
- Zu unserem meistverkauften PRKACA ELISA Kit
- Top Product
- Discover our top product PRKACA ELISA Kit
-
-
- Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
- Plattentyp
- Pre-coated
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Haltbarkeit
- 6 months
-
- Target Alle PRKACA ELISA Kits anzeigen
- PRKACA (Protein Kinase A, alpha (PRKACA))
- Andere Bezeichnung
- cAMP-Dependent Protein Kinase Catalytic Subunit alpha (PRKACA Produkte)
- Pathways
- NF-kappaB Signalweg, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-